Reports from Phase III Trials of CHOP-Containing Regimens for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)


Reports from Phase III Trials of CHOP-Containing Regimens for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Slides from presentations at ASCO 2011 and comments from John P Leonard, MD

Cunningham D et al. R-CHOP14 versus R-CHOP21: Result of a randomized Phase III trial for the treatment of patients with newly diagnosed diffuse large B-cell lymphoma. Proc ASCO 2011;Abstract 8000.

Dr Leonard is the Richard T Silver Distinguished Professor of Hematology and Medical Oncology and Professor of Medicine at Weill Cornell Medical College in New York, New York.